Caseware UK (AP4) 2023.0.135 2023.0.135 2024-06-302024-06-30true2023-07-01falsefalse2The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.falseNo description of principal activity2 04020696 2023-07-01 2024-06-30 04020696 2022-07-01 2023-06-30 04020696 2024-06-30 04020696 2023-06-30 04020696 c:Director2 2023-07-01 2024-06-30 04020696 d:OfficeEquipment 2023-07-01 2024-06-30 04020696 d:OfficeEquipment 2024-06-30 04020696 d:OfficeEquipment 2023-06-30 04020696 d:CurrentFinancialInstruments 2024-06-30 04020696 d:CurrentFinancialInstruments 2023-06-30 04020696 d:CurrentFinancialInstruments d:WithinOneYear 2024-06-30 04020696 d:CurrentFinancialInstruments d:WithinOneYear 2023-06-30 04020696 d:ShareCapital 2024-06-30 04020696 d:ShareCapital 2023-06-30 04020696 d:RetainedEarningsAccumulatedLosses 2024-06-30 04020696 d:RetainedEarningsAccumulatedLosses 2023-06-30 04020696 c:FRS102 2023-07-01 2024-06-30 04020696 c:AuditExempt-NoAccountantsReport 2023-07-01 2024-06-30 04020696 c:FullAccounts 2023-07-01 2024-06-30 04020696 c:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 04020696 e:PoundSterling 2023-07-01 2024-06-30 iso4217:GBP xbrli:pure

Registered number: 04020696










TNMC MEDIICAL DEVICES (UK) LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 JUNE 2024

 
TNMC MEDIICAL DEVICES (UK) LIMITED
REGISTERED NUMBER:04020696

BALANCE SHEET
AS AT 30 JUNE 2024

2024
2023
Note
£
£

  

Tangible assets
 4 
-
-

  
-
-

Current assets
  

Bank and cash balances
  
12,932
10,023

  
12,932
10,023

Creditors: amounts falling due within one year
 5 
(32,886)
(26,802)

Net current liabilities
  
 
 
(19,954)
 
 
(16,779)

  

Net liabilities
  
(19,954)
(16,779)


Capital and reserves
  

Called up share capital 
  
1,000
1,000

Profit and loss account
  
(20,954)
(17,779)

  
(19,954)
(16,779)


Page 1

 
TNMC MEDIICAL DEVICES (UK) LIMITED
REGISTERED NUMBER:04020696
    
BALANCE SHEET (CONTINUED)
AS AT 30 JUNE 2024

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The Company's financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 24 March 2025.




A Ten Napel
Director

The notes on pages 3 to 5 form part of these financial statements.

Page 2

 
TNMC MEDIICAL DEVICES (UK) LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

1.


General information

TNMC Mediical Devices (UK) Limited is a private company, limited by shares, incorporated in England and Wales, registered number 04020696. Its registered office is 910 The Crescent, Colchester Business Park, Colchester, Essex, CO4 9YQ. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

The following principal accounting policies have been applied:

 
2.2

Going concern

The financial statements have been prepared on the going concern basis which is dependent on continued financial support of fellow group companies and the Director.

 
2.3

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Office equipment
-
25%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.4

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Page 3

 
TNMC MEDIICAL DEVICES (UK) LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

2.Accounting policies (continued)

 
2.5

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees




The average monthly number of employees, including the director, during the year was as follows:


        2024
        2023
            No.
            No.







Employees
2
2


4.


Tangible fixed assets





Office equipment

£



Cost or valuation


At 1 July 2023
2,587



At 30 June 2024

2,587



Depreciation


At 1 July 2023
2,587



At 30 June 2024

2,587



Net book value



At 30 June 2024
-



At 30 June 2023
-

Page 4

 
TNMC MEDIICAL DEVICES (UK) LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

5.


Creditors: Amounts falling due within one year

2024
2023
£
£

Trade creditors
1,560
1,486

Amounts owed to group undertakings
12,686
6,860

Other creditors
17,275
17,511

Accruals and deferred income
1,365
945

32,886
26,802


 
Page 5